Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

AZ and Regeneron will collaborate on finding small-molecule drugs directed against the GPR75 target, splitting the costs of the programme ... follow-up GLP-1 agonist Ozempic (semaglutide) has ...

Lixisenatide is an older drug in the same class as Novo Nordisk’s big-selling Ozempic/Wegovy (semaglutide), used to treat type 2 diabetes and obesity, as well as to reduce the risk of ...

"Imagine that you're there," says my guide, George Buss, stepping onto the four-foot-high concrete replica of a speaker's platform, installed here in 1992 to memorialize the debate. He places a ...